m+Medelevator.RU
← Поиск публикаций
Journal of family medicine and primary care · 2025

Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Sujiv Akkilagunta, Lakshmi N R Aiswarya, Deshmukh Pradeep Ramrao, Tripathy Jaya Prasad, Khan Mubashshera F, Thomas Victoria

Аннотация

INTRODUCTION: Mucormycosis, a rare but serious fungal infection, surged during the second wave of the COVID-19 pandemic. Despite various proposed causative factors, published data are limited. This study aimed to identify risk factors for COVID-19-associated mucormycosis.

METHODS: A case-control study was conducted in the Nagpur district. Cases were recruited from suspected or confirmed mucormycosis cases reported to district health authorities. Controls were household members who had COVID-19 but did not develop mucormycosis. Predisposing and treatment-related factors were analyzed.

RESULTS: Analysis revealed significant associations between mucormycosis and diabetes mellitus (OR-10.8; CI-1.1-103.6) and corticosteroid use (OR-97.6; CI-3.2-2927.1). Factors such as humidifier use and mask usage did not show a significant association.

CONCLUSION: Optimal use of oxygen and corticosteroids is crucial, particularly in diabetic COVID-19 patients, to prevent mucormycosis.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты